Syngene FY26 profit falls 20%, revenue rises 3%
2h agoen
From the article
Annual report attributes decline to destocking by its largest biologics manufacturing client
Continue reading on thehindubusinessline.comYou might also wanna read
Biogen's Q2 2026 Earnings: What to Expect
Barchart·5h ago
Celltrion Poised for Profitability Leap on New Biosimilars
Seoul Economic Daily·3d ago
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
Bars·5d ago
Major drugmaker loses $27 billion in market value after failed trial
MarketWatch·8h ago
Panel Discussion—Biologics Breakthrough: Cutting Costs While Expanding Global Reach
bioprocessintl.com·1d ago
General Mills embraces protein innovation and launches $3 billion savings initiative
foodnavigator-usa.com·7d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.